Evidence map›Paper›PMID 35579963›Full record

ArticleThe Journal of clinical investigation2022

Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naive B cells.

Daniela Gómez Atria, Brian T Gaudette, Jennifer Londregan, Samantha Kelly, Eric Perkey, Anneka Allman, Bhaskar Srivastava, Ute Koch, Freddy Radtke, Burkhard Ludewig and 7 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Daniela Gómez AtriaDivision of Hematology/Oncology, Department of Medicine.
Brian T GaudetteDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, and.
Jennifer LondreganDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, and.
Samantha KellyDivision of Hematology/Oncology, Department of Medicine.
Eric PerkeyDivision of Hematology/Oncology, Department of Medicine.
Anneka AllmanDivision of Hematology/Oncology, Department of Medicine.
Bhaskar SrivastavaDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, and.
Ute KochEPFL, Lausanne, Switzerland.
Freddy RadtkeEPFL, Lausanne, Switzerland.
Burkhard LudewigMedical Research Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Christian W SiebelDepartment of Discovery Oncology, Genentech, South San Francisco, California, USA.
Russell Jh RyanDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Tanner F RobertsonImmunology Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Janis K BurkhardtImmunology Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Warren S PearDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, and.
David AllmanDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, and.
Ivan MaillardDivision of Hematology/Oncology, Department of Medicine.
University of Pennsylvania · USChildren's Hospital of Philadelphia · USÉcole Polytechnique Fédérale de Lausanne · CHUniversity of Michigan · USKantonsspital St. Gallen · CH

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
Proteasome Targeting for Alloreactive Plasma CellsR01AI154932 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ALLMAN, DAVID M, HILDEMAN, DAVID A · 2020 to 2025
$7.2M
Notch Signaling in AlloimmunityR01AI091627 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI PEAR, WARREN S · 2011 to 2025
$6.0M
Very early plasma cell differentiationR01AI139123 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ALLMAN, DAVID M, ARGON, YAIR · 2018 to 2022
$3.0M
Targeting the Notch:Myc axis in leukemia/lymphomaR01CA215518 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PEAR, WARREN S · 2018 to 2022
$2.3M
Oncogenic programs driven by Notch signaling in B-cell lymphomaK08CA208013 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RYAN, RUSSELL JAMES HUBBARD · 2016 to 2020
$791k
The role of secondary lymphoid organ fibroblastic cells in alloimmunityF30AI136315 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PERKEY, ERIC THOMAS · 2018 to 2021
$166k
NCI NIH HHS K08 CA208013NCI NIH HHS R01 CA215518NCI NIH HHS T32 CA009140NIAID NIH HHS F30 AI136315NIAID NIH HHS R01 AI091627NIAID NIH HHS R01 AI139123NIAID NIH HHS R01 AI154932NIAID NIH HHS T32 AI007632NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

In lymphopenic environments, secondary lymphoid organs regulate the size of B and T cell compartments by supporting the homeostatic proliferation of mature lymphocytes. The molecular mechanisms underlying these responses and their functional consequences remain incompletely understood. To evaluate homeostasis of the mature B cell pool during lymphopenia, we turned to an adoptive transfer model of purified follicular B cells into Rag2-/- mouse recipients. Highly purified follicular B cells transdifferentiated into marginal zone-like B cells when transferred into Rag2-/- lymphopenic hosts but not into wild-type hosts. In lymphopenic spleens, transferred B cells gradually lost their follicular phenotype and acquired characteristics of marginal zone B cells, as judged by cell surface phenotype, expression of integrins and chemokine receptors, positioning close to the marginal sinus, and an ability to rapidly generate functional plasma cells. Initiation of follicular to marginal zone B cell transdifferentiation preceded proliferation. Furthermore, the transdifferentiation process was dependent on Notch2 receptors in B cells and expression of Delta-like 1 Notch ligands by splenic Ccl19-Cre+ fibroblastic stromal cells. Gene expression analysis showed rapid induction of Notch-regulated transcripts followed by upregulated Myc expression and acquisition of broad transcriptional features of marginal zone B cells. Thus, naive mature B cells are endowed with plastic transdifferentiation potential in response to increased stromal Notch ligand availability during lymphopenia.

Indexed as

LymphopeniaAnimalsB-LymphocytesCell ProliferationHomeostasisMiceMice, Inbred C57BLAdaptive immunityImmunoglobulinsImmunology

Identifiers

PMID35579963
PMCPMC9246379
OpenAlexW4280517249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.